Bastion Therapeutics Alternatives & Competitors

12 companies similar to Bastion Therapeutics — Creating a future where inflammatory disorders are curable

Cellenkos, Inc.

Developing off-the-shelf T regulatory (Treg) cell therapies for rare inflammatory diseases...

14 Series A $15.00M

Biotechnology

Aegle Therapeutics

Developing extracellular vesicle (EV) therapies to address rare and serious diseases and d...

7 Convertible Note $13.50M

Woburn, United States

Biotechnology Health and Wellness

Shaperon

Delivering the future of IMMUNOLOGY

23 Series C $26.00B

Seoul, Korea South

Biopharma Biotechnology

Dualitas Therapeutics

Pioneering the Future of Bispecific Antibody Therapies

21 Series A $65.00M

Biotechnology

Track all Bastion Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Tridek-One

We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...

12 Venture round $19.00M

Paris, France

Biotechnology Health Care +1

Mozart Therapeutics, Inc.

Orchestrating the Immune System

36 Series A $80.00M

Seattle, United States

Biotechnology

Creative BioTherapeutics LLC

An emerging biotech discovering & developing novel therapies for cancer and viruses where...

6 $1.43M

Gurnee, United States

Biotechnology Health Care

Alector

We are on a mission to make brain disorders history.

141 IPO $495.50M

South San Francisco, Unit...

Biotechnology Health Care +2

Tolerx, Inc.

9 Venture round $145.50M

Cambridge, United States

Biotechnology Health Care

PIN Pharma

A pioneering biopharmaceutical firm dedicated to creating broad-based immuno-modulatory th...

Series A $6.75M

Biotechnology Pharmaceutical

VBL Therapeutics (Nasdaq:VBLT)

Engineering the future of targeted medicines, breaking barriers to develop the next genera...

15 Post-IPO Equity $62.76M

Israel

Biotechnology Health Care +1

Tizona Therapeutics, Inc.

Harnessing the power of the immune system to develop treatments for cancer.

23 $343.00M

South San Francisco, Unit...

Biotechnology

About Bastion Therapeutics

Bastion Therapeutics, founded in 2018 and headquartered in the United Kingdom, is a preclinical stage biotech company with a compelling vision: Creating a future where inflammatory disorders are curable. Focused on developing innovative Treg cell therapies, the company targets the vast unmet clinical needs of inflammat...

Taxonomy

Treg Cell Therapies, Inflammatory Disorders, Preclinical Stage, Immune Modulation, GRIT™ Platform Technology, Novel Therapies, Cell Engineering, Immune System Enhancement, Life Sciences, Therapeutic Development, Biomedical Innovation

Frequently Asked Questions

Companies similar to Bastion Therapeutics include Cellenkos, Inc., Aegle Therapeutics, Shaperon, Dualitas Therapeutics, Tridek-One. They work in Biotechnology and share Bastion Therapeutics's focus on inflammatory disorders, immune modulation and novel therapies.

Bounce Watch lists 12 companies that share Bastion Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Bastion Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Bastion Therapeutics Profile Cellenkos, Inc. Alternatives Aegle Therapeutics Alternatives Tridek-One Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Bastion Therapeutics on 5 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.